A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...

Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.

Phillip Chan; Chief Executive Officer, Director; Cytosorbents Corp. Peter Mariani; Chief Financial Officer; Cyt ...

Chances are, if you think you (ED), you’ve already looked into dietary supplements — and pretty much any option other than ...